Home LiteratureArticle Details
PMID: 344117 Published · ppublish English Journal Article

Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes.

Diabetes ·Vol. 27 Suppl 1 ·1978-00-00 ·Pages 262-4

Madsbad S, Faber OK, Binder C, McNair P, Christiansen C, Transbøl I

Abstract

The influence of the age at onset as well as the duration of disease on the prevalence of residual beta-cell function was studied in insulin-dependent diabetic patients. Two hundred and sixty-seven patients presented at an early age (10-19.9 years) and 158 patients had a late onset (30-39.9 years of age). beta-cell function was evaluated by measuring serum C-peptide immunoreactivity. Fifty-six patients (21.0 per cent) in the early-onset group and 64 (40.5 per cent) in the late-onset group had residual beta-cell function. The prevalence of residual beta-cell function was almost 100 per cent during the first two years of disease and was lower thereafter in diabetics with early onset. About 15 per cent of all patients with a duration between 15 and 35 years had residual beta-cell secretory function.

MeSH Terms
Adolescent Adult Age Factors C-Peptide/blood Child Diabetes Mellitus/drug therapy,physiopathology Diabetes Mellitus, Type 1/drug therapy,physiopathology Humans Insulin/therapeutic use Islets of Langerhans/physiopathology Radioimmunoassay
Chemicals
C-Peptide Insulin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Madsbad S
Faber O K
Binder C
McNair P
Christiansen C
Transbøl I
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
0012-1797
Published
1978-00-00
Pages
262-4
Language
English
Region
United States
NLM ID
0372763
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]